Transplantation Reviews is a premier scholarly journal published by Elsevier Science Inc, dedicated to advancing the field of transplantation and surgery. With an impressive impact factor and categorized in the top quartile (Q1) for both Surgery and Transplantation as of 2023, this journal prominently ranks in the 96th and 86th percentiles for its respective disciplines. Since its inception in 1987, it has provided a vital platform for researchers and professionals to disseminate high-quality, peer-reviewed articles that reflect the latest advancements and challenges in transplantation science. Although the journal is not currently open access, it remains a key resource for academic libraries and institutions. By fostering discussions and providing insights into clinical practices, Transplantation Reviews serves to enhance understanding and improve outcomes in the ever-evolving field of transplantation, making it an essential read for anyone engaged in this dynamic area of medicine.

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.

LIVER TRANSPLANTATION, published by Lippincott Williams & Wilkins, stands at the forefront of hepatology and transplantation research, with a prestigious Q1 rating across the categories of Hepatology, Surgery, and Transplantation as of 2023. Since its inception in 2000, this journal has been dedicated to disseminating high-quality, cutting-edge research that advances the understanding and practice of liver transplantation. With an impressive ranking of 23rd out of 551 in Surgery and 9th out of 54 in Transplantation, it occupies an esteemed position in the academic landscape, attracting contributions from leading experts in the field. The journal's rigorous peer-review process ensures the publication of impactful studies, innovative clinical practices, and vital insights into patient management. By fostering a collaborative environment for researchers, clinicians, and students alike, LIVER TRANSPLANTATION serves as an essential resource for those engaged in the complexities of liver transplantation and related fields. Join the community committed to advancing liver health and transplantation science.

Clinical Management Issues, published by SEED MEDICAL PUBLISHERS, is a premier Open Access journal dedicated to the advancement of clinical practice and management within the healthcare sector. Since its inception in 2007, this journal has aimed to provide a platform for original research, insightful reviews, and case studies that address pressing clinical management challenges faced by healthcare professionals today. Although the journal's coverage in Scopus has been discontinued since 2016, it continues to represent a wealth of knowledge for practitioners seeking evidence-based strategies and innovative solutions in patient care. Located in Torino, Italy, Clinical Management Issues serves as a vital resource for researchers, professionals, and students, fostering interdisciplinary collaborations to enhance clinical outcomes and optimize healthcare services.

Iraqi Journal of Hematology is a prominent peer-reviewed open-access journal dedicated to advancing the field of hematology. Published by Wolters Kluwer Medknow Publications, this journal provides a platform for researchers, professionals, and students to share cutting-edge findings and developments in various aspects of hematology, including blood diseases, diagnostics, and innovative treatments. Since its transition to open access in 2016, the journal has significantly increased its reach, allowing for wider dissemination of critical research to a global audience. With an ISSN of 2072-8069 and an E-ISSN of 2543-2702, the Iraqi Journal of Hematology strives to adhere to the highest scholarly standards and plays a vital role in the ongoing discourse in hematological research. Researchers are encouraged to contribute to this essential resource for the scientific community, contributing to the advancement of knowledge that ultimately improves patient care and treatment outcomes.

CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.

Transplantation and Cellular Therapy is a leading journal published by Elsevier Science Inc, dedicated to advancing the fields of transplantation, immunology, cell biology, and molecular medicine. With its ISSN of 2666-6375 and E-ISSN 2666-6367, this journal serves as a vital resource for researchers, practitioners, and students aiming to stay at the forefront of innovative therapies and clinical practices in transplantation. As of 2023, it holds an impressive Q1 ranking in multiple categories, including Cell Biology, Hematology, Immunology and Allergy, Molecular Medicine, and Transplantation, reflecting its high impact and relevance in the scientific community. The journal, operating from its base in the Netherlands, supports Open Access publishing to enhance the dissemination and accessibility of groundbreaking research. Acknowledging the significance of transplantation and cellular therapies in modern medicine, Transplantation and Cellular Therapy is poised to propel future discoveries and developments in these critical domains.

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

TRANSPLANTATION PROCEEDINGS is a distinguished journal published by Elsevier Science Inc, focused on the field of transplantation and surgery. With a publication history spanning over five decades, from 1969 to 2024, this journal has consistently provided a platform for researchers and practitioners to share significant findings and advancements in organ transplantation and related surgical techniques. The journal is renowned for its rigorous peer-review process and has achieved a respectable impact factor within its categories, ranking in the Q3 quartile for both Surgery and Transplantation as of 2023. With Scopus rankings placing it in the 47th percentile in Medicine (Surgery) and the 43rd percentile in Medicine (Transplantation), TRANSPLANTATION PROCEEDINGS serves as a vital resource for academics and medical professionals seeking to stay updated on the latest empirical research, clinical practices, and innovative methodologies in the field. While it does not operate under an open-access model, the journal ensures that critical insights and data are accessible to its audience, enhancing the global discourse in transplantation science. For those dedicated to advancing transplant medicine, this journal represents an invaluable collection of knowledge and a forum for fostering innovative approaches to improve patient outcomes.